Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy D Bloom

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
Clinical Transplantation|March 20, 2019
Single-center, real-world experience with granulocyte colony-stimulating factor for management of leukopenia following kidney transplantationStephanie Hamel, Vicky Kuo, Deirdre Sawinski, et al.
Clinical Transplantation|May 10, 2007
Effects of sirolimus vs. calcineurin inhibitors on renal dysfunction after orthotopic liver transplantationMical S Campbell, Jitha Rai, Elliott Kozin, et al.
Transplantation Proceedings|February 27, 2022
Active Tuberculosis After Solid Organ Transplantation in Individuals With Negative Pretransplant QuantiFERON-TB Gold Testing: A Case SeriesRebecca Wang, Sarah A Longworth, Jeffrey B Doyon, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 23, 2017
Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant RecipientsJennifer Trofe-Clark, Daniel C Brennan, Patricia West-Thielke, et al.
Transplantation|August 17, 2012
Efficacy and safety of extended-duration inpatient-to-outpatient rabbit antithymocyte globulin induction in de novo kidney transplant recipients: 6-month outcomesJennifer Trofe-Clark, Peter P Reese, Hina J Patel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 12, 2025
2025 Report of the Sensitization in Transplantation: Assessment of Risk Working Group on donor-derived cell-free DNA: Establishing analytical validity as the basis for appropriate and effective clinical utilizationNicole M Valenzuela, James Lan, Kelley M K Hitchman, et al.
Transplantation|August 21, 2010
Association of metabolic syndrome with development of new-onset diabetes after transplantationNathaniel D Bayer, Philip T Cochetti, Mysore S Anil Kumar, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 27, 2010
Determinants of the decision to accept a kidney from a donor at increased risk for blood-borne viral infectionPeter P Reese, Tara Tehrani, Mary Ann Lim, et al.
Pediatric Transplantation|June 19, 2019
The effect of transfer to adult transplant care on kidney function and immunosuppressant drug level variability in pediatric kidney transplant recipientsHilda E Fernandez, Sandra Amaral, Pamela A Shaw, et al.
Transplantation Direct|November 18, 2020
Financial Evaluation of Kidney Transplant With Hepatitis C Viremic Donors to Uninfected RecipientsDavid A Axelrod, Krista L Lentine, Ramji Balakrishnan, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Clinical Transplantation|March 20, 2019
Single-center, real-world experience with granulocyte colony-stimulating factor for management of leukopenia following kidney transplantationStephanie Hamel, Vicky Kuo, Deirdre Sawinski, et al.
Clinical Transplantation|May 10, 2007
Effects of sirolimus vs. calcineurin inhibitors on renal dysfunction after orthotopic liver transplantationMical S Campbell, Jitha Rai, Elliott Kozin, et al.
Transplantation Proceedings|February 27, 2022
Active Tuberculosis After Solid Organ Transplantation in Individuals With Negative Pretransplant QuantiFERON-TB Gold Testing: A Case SeriesRebecca Wang, Sarah A Longworth, Jeffrey B Doyon, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 23, 2017
Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant RecipientsJennifer Trofe-Clark, Daniel C Brennan, Patricia West-Thielke, et al.
Transplantation|August 17, 2012
Efficacy and safety of extended-duration inpatient-to-outpatient rabbit antithymocyte globulin induction in de novo kidney transplant recipients: 6-month outcomesJennifer Trofe-Clark, Peter P Reese, Hina J Patel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 12, 2025
2025 Report of the Sensitization in Transplantation: Assessment of Risk Working Group on donor-derived cell-free DNA: Establishing analytical validity as the basis for appropriate and effective clinical utilizationNicole M Valenzuela, James Lan, Kelley M K Hitchman, et al.
Transplantation|August 21, 2010
Association of metabolic syndrome with development of new-onset diabetes after transplantationNathaniel D Bayer, Philip T Cochetti, Mysore S Anil Kumar, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 27, 2010
Determinants of the decision to accept a kidney from a donor at increased risk for blood-borne viral infectionPeter P Reese, Tara Tehrani, Mary Ann Lim, et al.
Pediatric Transplantation|June 19, 2019
The effect of transfer to adult transplant care on kidney function and immunosuppressant drug level variability in pediatric kidney transplant recipientsHilda E Fernandez, Sandra Amaral, Pamela A Shaw, et al.
Transplantation Direct|November 18, 2020
Financial Evaluation of Kidney Transplant With Hepatitis C Viremic Donors to Uninfected RecipientsDavid A Axelrod, Krista L Lentine, Ramji Balakrishnan, et al.
Pageof 13